Profilo
Kyler Lei is currently Chief Financial Officer at NovaBridge Biosciences since 2025.
Formerly, Mr. Lei was Deputy General Manager & Head-Capital Markets at Sino Biopharmaceutical Ltd. from 2022 to 2025, Research Analyst at Daiwa Capital Markets (Hong Kong) Ltd. from 2020 to 2021, and Analyst at Macquarie Capital Ltd. from 2018 to 2020.
Education includes an undergraduate degree from The University of Hong Kong conferred in 2019 and a graduate degree from The Hong Kong University of Science & Technology conferred in 2022.
Posizioni attive di Kyler Lei
| Società | Posizione | Inizio |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Direttore Finanziario/CFO | 16/10/2025 |
Precedenti posizioni note di Kyler Lei
| Società | Posizione | Fine |
|---|---|---|
| SINO BIOPHARMACEUTICAL LIMITED | Corporate Officer/Principal | 01/10/2025 |
Daiwa Capital Markets (Hong Kong) Ltd.
Daiwa Capital Markets (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/06/2021 |
Macquarie Capital Ltd.
Macquarie Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/06/2020 |
Formazione di Kyler Lei
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Sino Biopharmaceutical Ltd.
Sino Biopharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company, which engages in the manufacturing and selling of pharmaceutical products | Health Technology |
University of Hong Kong
University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Macquarie Capital Ltd.
Macquarie Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Hong Kong University of Science & Technology
The Hong Kong University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiwa Capital Markets (Hong Kong) Ltd.
Daiwa Capital Markets (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
















